BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Napo Pharmaceuticals, Inc. 

185 Berry Street
Suite 1300
South San Francisco  California  94080  U.S.A.
Phone: 415-371-8300 Fax: 415-371-8311


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Pharmaceutical






 Company News
Salix Pharmaceuticals, Ltd. (SLXP) Wins Napo Pharmaceuticals, Inc. Litigation 2/26/2014 6:58:39 AM    More...
Trial Date Set for Napo Pharmaceuticals, Inc. Breach of Contract Claim Against Salix Pharmaceuticals, Ltd. (SLXP) 11/4/2013 10:04:34 AM    More...
Napo Pharmaceuticals, Inc. Files for MUMS Designation for Crofelemer for Chemotherapy Induced Diarrhea in Dogs 9/13/2012 10:25:52 AM    More...
The International Centre for Dispute Resolution Has Ruled in Favor of Glenmark Pharmaceuticals on the Arbitration Claim It Filed Against Napo Pharmaceuticals, Inc. 8/23/2012 10:29:03 AM    More...
Napo Pharmaceuticals, Inc. Comments on FDA Announcing Extension of Crofelemer NDA Priority Review 5/4/2012 6:41:11 AM    More...
Napo Pharmaceuticals, Inc. Release: New Treatment Presented for Chronic Diarrhea in HIV/AIDS Patients 3/9/2012 6:32:52 AM    More...
Napo Pharmaceuticals, Inc. Release: FDA Grants PDUFA Date of June 5, 2012 for Crofelemer 2/8/2012 6:47:19 AM    More...
Napo Pharmaceuticals, Inc. Secures Dismissal of Legal Action 1/11/2012 7:31:54 AM    More...
Glenmark Pharmaceuticals and Napo Pharmaceuticals, Inc. Go to Arbitration Over Collaboration 12/14/2011 8:36:45 AM    More...
Napo Pharmaceuticals, Inc. Terminates Glenmark Pharmaceuticals for Failure to Commercially Develop Crofelemer 12/12/2011 11:15:03 AM    More...
12345